For the Inventor, By the Inventor

Enter assignee name

Morris Plains, NJ, United States of America

Immunomedics, Inc.

USPTO Granted Patents = 410

CIPO Patents = 18

EPO Patents = 71

Trademarks = 12

Forward Citations = 10,747

Loading Chart...

Loading Chart...

73 inventors (with patents filed for the assignee):

David M Goldenberg (297 out of 393 patents)

Hans J Hansen (178 out of 191 patents)

Serengulam V Govindan (110 out of 112 patents)

4. Chien-Hsing Chang (75 out of 140 patents)

5. Zhengxing Qu (63 out of 65 patents)

6. William John McBride (60 out of 85 patents)

7. Gary L Griffiths (56 out of 63 patents)

8. Sung-Ju Moon (28 out of 28 patents)

9. Edmund A Rossi (27 out of 77 patents)

10. Shui-on Leung (24 out of 24 patents)

11. Christopher A D'Souza (19 out of 19 patents)

12. Milton D Goldenberg (17 out of 26 patents)

13. David V Gold (12 out of 12 patents)

14. Thomas M Cardillo (9 out of 9 patents)

15. Jeng-Dar Yang (9 out of 9 patents)

Core Competencies:

Antibody-Drug Conjugates

Immunoconjugates

SN-38

Trop-2

HLA-DR Antibodies

Combination Therapy

Checkpoint Inhibitors

Microtubule Inhibitors

PARP Inhibitors

Therapeutic Outcomes

Hematologic Malignancies

Chimeric Antibodies

410 patents: Sort by Forward Citations

1. 12364761 - Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity (2025-07-22),

2. 12310958 - Antibody-drug conjugates and uses thereof (2025-05-27),

3. 12251441 - Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity (2025-03-18),

4. 11541047 - Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity (2023-01-03),

5. 11439620 - Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors (2022-09-13),

6. 11253606 - Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer (2022-02-22),

7. 11192955 - Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors (2021-12-07),

8. 11180559 - Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies (2021-11-23),

9. RE48751 - Immunoconjugates with an intracellularly-cleavable linkage (2021-09-27),

10. 11116846 - Antibody-drug conjugates and uses thereof (2021-09-14),

11. 11077201 - Immunoconjugates with an intracellularly-cleavable linkage (2021-08-03),

12. 11066468 - Immunoconjugates with an intracellularly-cleavable linkage (2021-07-20),

13. 11052156 - Antibody-drug conjugates and uses thereof (2021-07-06),

14. 11052081 - Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132) (2021-07-06),

15. 11020489 - Immunoconjugates with an intracellularly-cleavable linkage (2021-06-01),

Immunomedics, Inc. is a biopharmaceutical company dedicated to developing innovative antibody-based therapies for the treatment of cancer. With a focus on antibody-drug conjugates (ADCs), Immunomedics aims to provide targeted and effective treatments that can improve outcomes for patients. Supported by a strong pipeline of product candidates, the company is committed to advancing the science of cancer therapeutics. Visit their website to learn more about Immunomedics and their groundbreaking research and developments in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

410 Patents

#3 in Morris Plains, NJ

#60 in New Jersey

#1,107 in US

#2,223 in the World

Morris Plains, NJ, United States of America

Immunomedics, Inc.

Forward Citations = 10,747

73 inventors:

David M Goldenberg (297 out of 393 patents)

Hans J Hansen (178 out of 191 patents)

Serengulam V Govindan (110 out of 112 patents)

4. Chien-Hsing Chang (75 out of 140 patents)

5. Zhengxing Qu (63 out of 65 patents)

Please report any incorrect information to support@idiyas.com

Loading…